Global Insulin API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 117

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Insulin API market size was valued at USD 1796.1 million in 2023 and is forecast to a readjusted size of USD 2175.5 million by 2030 with a CAGR of 2.8% during review period.

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

The Global Info Research report includes an overview of the development of the Insulin API industry chain, the market status of Fast-Acting (Regular Human Insulin, Insulin Analogue), Premix (Regular Human Insulin, Insulin Analogue), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Insulin API.

Regionally, the report analyzes the Insulin API markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Insulin API market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Insulin API market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Insulin API industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Regular Human Insulin, Insulin Analogue).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Insulin API market.

Regional Analysis: The report involves examining the Insulin API market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Insulin API market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Insulin API:
Company Analysis: Report covers individual Insulin API manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Insulin API This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Fast-Acting, Premix).

Technology Analysis: Report covers specific technologies relevant to Insulin API. It assesses the current state, advancements, and potential future developments in Insulin API areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Insulin API market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Insulin API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Regular Human Insulin
Insulin Analogue

Market segment by Application
Fast-Acting
Premix
Long-Acting

Major players covered
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Insulin API, with price, sales, revenue and global market share of Insulin API from 2019 to 2024.
Chapter 3, the Insulin API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Insulin API market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Insulin API.
Chapter 14 and 15, to describe Insulin API sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Insulin API
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Insulin API Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Regular Human Insulin
        1.3.3 Insulin Analogue
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Insulin API Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Fast-Acting
        1.4.3 Premix
        1.4.4 Long-Acting
    1.5 Global Insulin API Market Size & Forecast
        1.5.1 Global Insulin API Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Insulin API Sales Quantity (2019-2030)
        1.5.3 Global Insulin API Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Novo Nordisk
        2.1.1 Novo Nordisk Details
        2.1.2 Novo Nordisk Major Business
        2.1.3 Novo Nordisk Insulin API Product and Services
        2.1.4 Novo Nordisk Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novo Nordisk Recent Developments/Updates
    2.2 Sanofi-Aventis
        2.2.1 Sanofi-Aventis Details
        2.2.2 Sanofi-Aventis Major Business
        2.2.3 Sanofi-Aventis Insulin API Product and Services
        2.2.4 Sanofi-Aventis Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sanofi-Aventis Recent Developments/Updates
    2.3 Eli Lilly
        2.3.1 Eli Lilly Details
        2.3.2 Eli Lilly Major Business
        2.3.3 Eli Lilly Insulin API Product and Services
        2.3.4 Eli Lilly Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Eli Lilly Recent Developments/Updates
    2.4 Tonghua Dongbao
        2.4.1 Tonghua Dongbao Details
        2.4.2 Tonghua Dongbao Major Business
        2.4.3 Tonghua Dongbao Insulin API Product and Services
        2.4.4 Tonghua Dongbao Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Tonghua Dongbao Recent Developments/Updates
    2.5 Ganlee
        2.5.1 Ganlee Details
        2.5.2 Ganlee Major Business
        2.5.3 Ganlee Insulin API Product and Services
        2.5.4 Ganlee Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Ganlee Recent Developments/Updates
    2.6 United Laboratory
        2.6.1 United Laboratory Details
        2.6.2 United Laboratory Major Business
        2.6.3 United Laboratory Insulin API Product and Services
        2.6.4 United Laboratory Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 United Laboratory Recent Developments/Updates
    2.7 Biocon
        2.7.1 Biocon Details
        2.7.2 Biocon Major Business
        2.7.3 Biocon Insulin API Product and Services
        2.7.4 Biocon Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Biocon Recent Developments/Updates
    2.8 Amphastar
        2.8.1 Amphastar Details
        2.8.2 Amphastar Major Business
        2.8.3 Amphastar Insulin API Product and Services
        2.8.4 Amphastar Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Amphastar Recent Developments/Updates
    2.9 Wockhardt
        2.9.1 Wockhardt Details
        2.9.2 Wockhardt Major Business
        2.9.3 Wockhardt Insulin API Product and Services
        2.9.4 Wockhardt Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Wockhardt Recent Developments/Updates
    2.10 Julphar Diabetes
        2.10.1 Julphar Diabetes Details
        2.10.2 Julphar Diabetes Major Business
        2.10.3 Julphar Diabetes Insulin API Product and Services
        2.10.4 Julphar Diabetes Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Julphar Diabetes Recent Developments/Updates
    2.11 Torrent Pharma
        2.11.1 Torrent Pharma Details
        2.11.2 Torrent Pharma Major Business
        2.11.3 Torrent Pharma Insulin API Product and Services
        2.11.4 Torrent Pharma Insulin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Torrent Pharma Recent Developments/Updates

3 Competitive Environment: Insulin API by Manufacturer
    3.1 Global Insulin API Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Insulin API Revenue by Manufacturer (2019-2024)
    3.3 Global Insulin API Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Insulin API by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Insulin API Manufacturer Market Share in 2023
        3.4.2 Top 6 Insulin API Manufacturer Market Share in 2023
    3.5 Insulin API Market: Overall Company Footprint Analysis
        3.5.1 Insulin API Market: Region Footprint
        3.5.2 Insulin API Market: Company Product Type Footprint
        3.5.3 Insulin API Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Insulin API Market Size by Region
        4.1.1 Global Insulin API Sales Quantity by Region (2019-2030)
        4.1.2 Global Insulin API Consumption Value by Region (2019-2030)
        4.1.3 Global Insulin API Average Price by Region (2019-2030)
    4.2 North America Insulin API Consumption Value (2019-2030)
    4.3 Europe Insulin API Consumption Value (2019-2030)
    4.4 Asia-Pacific Insulin API Consumption Value (2019-2030)
    4.5 South America Insulin API Consumption Value (2019-2030)
    4.6 Middle East and Africa Insulin API Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Insulin API Sales Quantity by Type (2019-2030)
    5.2 Global Insulin API Consumption Value by Type (2019-2030)
    5.3 Global Insulin API Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Insulin API Sales Quantity by Application (2019-2030)
    6.2 Global Insulin API Consumption Value by Application (2019-2030)
    6.3 Global Insulin API Average Price by Application (2019-2030)

7 North America
    7.1 North America Insulin API Sales Quantity by Type (2019-2030)
    7.2 North America Insulin API Sales Quantity by Application (2019-2030)
    7.3 North America Insulin API Market Size by Country
        7.3.1 North America Insulin API Sales Quantity by Country (2019-2030)
        7.3.2 North America Insulin API Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Insulin API Sales Quantity by Type (2019-2030)
    8.2 Europe Insulin API Sales Quantity by Application (2019-2030)
    8.3 Europe Insulin API Market Size by Country
        8.3.1 Europe Insulin API Sales Quantity by Country (2019-2030)
        8.3.2 Europe Insulin API Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Insulin API Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Insulin API Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Insulin API Market Size by Region
        9.3.1 Asia-Pacific Insulin API Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Insulin API Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Insulin API Sales Quantity by Type (2019-2030)
    10.2 South America Insulin API Sales Quantity by Application (2019-2030)
    10.3 South America Insulin API Market Size by Country
        10.3.1 South America Insulin API Sales Quantity by Country (2019-2030)
        10.3.2 South America Insulin API Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Insulin API Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Insulin API Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Insulin API Market Size by Country
        11.3.1 Middle East & Africa Insulin API Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Insulin API Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Insulin API Market Drivers
    12.2 Insulin API Market Restraints
    12.3 Insulin API Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Insulin API and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Insulin API
    13.3 Insulin API Production Process
    13.4 Insulin API Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Insulin API Typical Distributors
    14.3 Insulin API Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Insulin API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Insulin API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
    Table 4. Novo Nordisk Major Business
    Table 5. Novo Nordisk Insulin API Product and Services
    Table 6. Novo Nordisk Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Novo Nordisk Recent Developments/Updates
    Table 8. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
    Table 9. Sanofi-Aventis Major Business
    Table 10. Sanofi-Aventis Insulin API Product and Services
    Table 11. Sanofi-Aventis Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Sanofi-Aventis Recent Developments/Updates
    Table 13. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 14. Eli Lilly Major Business
    Table 15. Eli Lilly Insulin API Product and Services
    Table 16. Eli Lilly Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Eli Lilly Recent Developments/Updates
    Table 18. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
    Table 19. Tonghua Dongbao Major Business
    Table 20. Tonghua Dongbao Insulin API Product and Services
    Table 21. Tonghua Dongbao Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Tonghua Dongbao Recent Developments/Updates
    Table 23. Ganlee Basic Information, Manufacturing Base and Competitors
    Table 24. Ganlee Major Business
    Table 25. Ganlee Insulin API Product and Services
    Table 26. Ganlee Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Ganlee Recent Developments/Updates
    Table 28. United Laboratory Basic Information, Manufacturing Base and Competitors
    Table 29. United Laboratory Major Business
    Table 30. United Laboratory Insulin API Product and Services
    Table 31. United Laboratory Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. United Laboratory Recent Developments/Updates
    Table 33. Biocon Basic Information, Manufacturing Base and Competitors
    Table 34. Biocon Major Business
    Table 35. Biocon Insulin API Product and Services
    Table 36. Biocon Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Biocon Recent Developments/Updates
    Table 38. Amphastar Basic Information, Manufacturing Base and Competitors
    Table 39. Amphastar Major Business
    Table 40. Amphastar Insulin API Product and Services
    Table 41. Amphastar Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Amphastar Recent Developments/Updates
    Table 43. Wockhardt Basic Information, Manufacturing Base and Competitors
    Table 44. Wockhardt Major Business
    Table 45. Wockhardt Insulin API Product and Services
    Table 46. Wockhardt Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Wockhardt Recent Developments/Updates
    Table 48. Julphar Diabetes Basic Information, Manufacturing Base and Competitors
    Table 49. Julphar Diabetes Major Business
    Table 50. Julphar Diabetes Insulin API Product and Services
    Table 51. Julphar Diabetes Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Julphar Diabetes Recent Developments/Updates
    Table 53. Torrent Pharma Basic Information, Manufacturing Base and Competitors
    Table 54. Torrent Pharma Major Business
    Table 55. Torrent Pharma Insulin API Product and Services
    Table 56. Torrent Pharma Insulin API Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Torrent Pharma Recent Developments/Updates
    Table 58. Global Insulin API Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 59. Global Insulin API Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 60. Global Insulin API Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 61. Market Position of Manufacturers in Insulin API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 62. Head Office and Insulin API Production Site of Key Manufacturer
    Table 63. Insulin API Market: Company Product Type Footprint
    Table 64. Insulin API Market: Company Product Application Footprint
    Table 65. Insulin API New Market Entrants and Barriers to Market Entry
    Table 66. Insulin API Mergers, Acquisition, Agreements, and Collaborations
    Table 67. Global Insulin API Sales Quantity by Region (2019-2024) & (K Units)
    Table 68. Global Insulin API Sales Quantity by Region (2025-2030) & (K Units)
    Table 69. Global Insulin API Consumption Value by Region (2019-2024) & (USD Million)
    Table 70. Global Insulin API Consumption Value by Region (2025-2030) & (USD Million)
    Table 71. Global Insulin API Average Price by Region (2019-2024) & (USD/Unit)
    Table 72. Global Insulin API Average Price by Region (2025-2030) & (USD/Unit)
    Table 73. Global Insulin API Sales Quantity by Type (2019-2024) & (K Units)
    Table 74. Global Insulin API Sales Quantity by Type (2025-2030) & (K Units)
    Table 75. Global Insulin API Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Global Insulin API Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Global Insulin API Average Price by Type (2019-2024) & (USD/Unit)
    Table 78. Global Insulin API Average Price by Type (2025-2030) & (USD/Unit)
    Table 79. Global Insulin API Sales Quantity by Application (2019-2024) & (K Units)
    Table 80. Global Insulin API Sales Quantity by Application (2025-2030) & (K Units)
    Table 81. Global Insulin API Consumption Value by Application (2019-2024) & (USD Million)
    Table 82. Global Insulin API Consumption Value by Application (2025-2030) & (USD Million)
    Table 83. Global Insulin API Average Price by Application (2019-2024) & (USD/Unit)
    Table 84. Global Insulin API Average Price by Application (2025-2030) & (USD/Unit)
    Table 85. North America Insulin API Sales Quantity by Type (2019-2024) & (K Units)
    Table 86. North America Insulin API Sales Quantity by Type (2025-2030) & (K Units)
    Table 87. North America Insulin API Sales Quantity by Application (2019-2024) & (K Units)
    Table 88. North America Insulin API Sales Quantity by Application (2025-2030) & (K Units)
    Table 89. North America Insulin API Sales Quantity by Country (2019-2024) & (K Units)
    Table 90. North America Insulin API Sales Quantity by Country (2025-2030) & (K Units)
    Table 91. North America Insulin API Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. North America Insulin API Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Europe Insulin API Sales Quantity by Type (2019-2024) & (K Units)
    Table 94. Europe Insulin API Sales Quantity by Type (2025-2030) & (K Units)
    Table 95. Europe Insulin API Sales Quantity by Application (2019-2024) & (K Units)
    Table 96. Europe Insulin API Sales Quantity by Application (2025-2030) & (K Units)
    Table 97. Europe Insulin API Sales Quantity by Country (2019-2024) & (K Units)
    Table 98. Europe Insulin API Sales Quantity by Country (2025-2030) & (K Units)
    Table 99. Europe Insulin API Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe Insulin API Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific Insulin API Sales Quantity by Type (2019-2024) & (K Units)
    Table 102. Asia-Pacific Insulin API Sales Quantity by Type (2025-2030) & (K Units)
    Table 103. Asia-Pacific Insulin API Sales Quantity by Application (2019-2024) & (K Units)
    Table 104. Asia-Pacific Insulin API Sales Quantity by Application (2025-2030) & (K Units)
    Table 105. Asia-Pacific Insulin API Sales Quantity by Region (2019-2024) & (K Units)
    Table 106. Asia-Pacific Insulin API Sales Quantity by Region (2025-2030) & (K Units)
    Table 107. Asia-Pacific Insulin API Consumption Value by Region (2019-2024) & (USD Million)
    Table 108. Asia-Pacific Insulin API Consumption Value by Region (2025-2030) & (USD Million)
    Table 109. South America Insulin API Sales Quantity by Type (2019-2024) & (K Units)
    Table 110. South America Insulin API Sales Quantity by Type (2025-2030) & (K Units)
    Table 111. South America Insulin API Sales Quantity by Application (2019-2024) & (K Units)
    Table 112. South America Insulin API Sales Quantity by Application (2025-2030) & (K Units)
    Table 113. South America Insulin API Sales Quantity by Country (2019-2024) & (K Units)
    Table 114. South America Insulin API Sales Quantity by Country (2025-2030) & (K Units)
    Table 115. South America Insulin API Consumption Value by Country (2019-2024) & (USD Million)
    Table 116. South America Insulin API Consumption Value by Country (2025-2030) & (USD Million)
    Table 117. Middle East & Africa Insulin API Sales Quantity by Type (2019-2024) & (K Units)
    Table 118. Middle East & Africa Insulin API Sales Quantity by Type (2025-2030) & (K Units)
    Table 119. Middle East & Africa Insulin API Sales Quantity by Application (2019-2024) & (K Units)
    Table 120. Middle East & Africa Insulin API Sales Quantity by Application (2025-2030) & (K Units)
    Table 121. Middle East & Africa Insulin API Sales Quantity by Region (2019-2024) & (K Units)
    Table 122. Middle East & Africa Insulin API Sales Quantity by Region (2025-2030) & (K Units)
    Table 123. Middle East & Africa Insulin API Consumption Value by Region (2019-2024) & (USD Million)
    Table 124. Middle East & Africa Insulin API Consumption Value by Region (2025-2030) & (USD Million)
    Table 125. Insulin API Raw Material
    Table 126. Key Manufacturers of Insulin API Raw Materials
    Table 127. Insulin API Typical Distributors
    Table 128. Insulin API Typical Customers
List of Figures
    Figure 1. Insulin API Picture
    Figure 2. Global Insulin API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Insulin API Consumption Value Market Share by Type in 2023
    Figure 4. Regular Human Insulin Examples
    Figure 5. Insulin Analogue Examples
    Figure 6. Global Insulin API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Insulin API Consumption Value Market Share by Application in 2023
    Figure 8. Fast-Acting Examples
    Figure 9. Premix Examples
    Figure 10. Long-Acting Examples
    Figure 11. Global Insulin API Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Insulin API Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Insulin API Sales Quantity (2019-2030) & (K Units)
    Figure 14. Global Insulin API Average Price (2019-2030) & (USD/Unit)
    Figure 15. Global Insulin API Sales Quantity Market Share by Manufacturer in 2023
    Figure 16. Global Insulin API Consumption Value Market Share by Manufacturer in 2023
    Figure 17. Producer Shipments of Insulin API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 18. Top 3 Insulin API Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Top 6 Insulin API Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Global Insulin API Sales Quantity Market Share by Region (2019-2030)
    Figure 21. Global Insulin API Consumption Value Market Share by Region (2019-2030)
    Figure 22. North America Insulin API Consumption Value (2019-2030) & (USD Million)
    Figure 23. Europe Insulin API Consumption Value (2019-2030) & (USD Million)
    Figure 24. Asia-Pacific Insulin API Consumption Value (2019-2030) & (USD Million)
    Figure 25. South America Insulin API Consumption Value (2019-2030) & (USD Million)
    Figure 26. Middle East & Africa Insulin API Consumption Value (2019-2030) & (USD Million)
    Figure 27. Global Insulin API Sales Quantity Market Share by Type (2019-2030)
    Figure 28. Global Insulin API Consumption Value Market Share by Type (2019-2030)
    Figure 29. Global Insulin API Average Price by Type (2019-2030) & (USD/Unit)
    Figure 30. Global Insulin API Sales Quantity Market Share by Application (2019-2030)
    Figure 31. Global Insulin API Consumption Value Market Share by Application (2019-2030)
    Figure 32. Global Insulin API Average Price by Application (2019-2030) & (USD/Unit)
    Figure 33. North America Insulin API Sales Quantity Market Share by Type (2019-2030)
    Figure 34. North America Insulin API Sales Quantity Market Share by Application (2019-2030)
    Figure 35. North America Insulin API Sales Quantity Market Share by Country (2019-2030)
    Figure 36. North America Insulin API Consumption Value Market Share by Country (2019-2030)
    Figure 37. United States Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Canada Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Mexico Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Europe Insulin API Sales Quantity Market Share by Type (2019-2030)
    Figure 41. Europe Insulin API Sales Quantity Market Share by Application (2019-2030)
    Figure 42. Europe Insulin API Sales Quantity Market Share by Country (2019-2030)
    Figure 43. Europe Insulin API Consumption Value Market Share by Country (2019-2030)
    Figure 44. Germany Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. France Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. United Kingdom Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Russia Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Italy Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Asia-Pacific Insulin API Sales Quantity Market Share by Type (2019-2030)
    Figure 50. Asia-Pacific Insulin API Sales Quantity Market Share by Application (2019-2030)
    Figure 51. Asia-Pacific Insulin API Sales Quantity Market Share by Region (2019-2030)
    Figure 52. Asia-Pacific Insulin API Consumption Value Market Share by Region (2019-2030)
    Figure 53. China Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Japan Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Korea Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. India Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Southeast Asia Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Australia Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. South America Insulin API Sales Quantity Market Share by Type (2019-2030)
    Figure 60. South America Insulin API Sales Quantity Market Share by Application (2019-2030)
    Figure 61. South America Insulin API Sales Quantity Market Share by Country (2019-2030)
    Figure 62. South America Insulin API Consumption Value Market Share by Country (2019-2030)
    Figure 63. Brazil Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Argentina Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Middle East & Africa Insulin API Sales Quantity Market Share by Type (2019-2030)
    Figure 66. Middle East & Africa Insulin API Sales Quantity Market Share by Application (2019-2030)
    Figure 67. Middle East & Africa Insulin API Sales Quantity Market Share by Region (2019-2030)
    Figure 68. Middle East & Africa Insulin API Consumption Value Market Share by Region (2019-2030)
    Figure 69. Turkey Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Egypt Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Saudi Arabia Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. South Africa Insulin API Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Insulin API Market Drivers
    Figure 74. Insulin API Market Restraints
    Figure 75. Insulin API Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Insulin API in 2023
    Figure 78. Manufacturing Process Analysis of Insulin API
    Figure 79. Insulin API Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma

Related Reports

Global Insulin API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Insulin API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Global Insulin API Supply, Demand and Key Producers, 2024-2030

Global Insulin API Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global Insulin API market size is expected to reach $ 2175.5 million by 2030, rising at a market growth of 2.8% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>